Press release
C-MET Non-Small Cell Lung Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight
Explore our latest breakthroughs in C-MET Non-Small Cell Lung Cancer Research. Learn more about our innovative pipeline today! @ C-MET Non-Small Cell Lung Cancer Pipeline Outlook [https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the C-MET Non-Small Cell Lung Cancer Pipeline Report
* June 2024:- AbbVie- A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer.
* May 2024: Apollomics Inc.- Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors.
* DelveInsight's C-MET Non-Small Cell Lung Cancer pipeline report depicts a robust space with 5+ active players working to develop 5+ pipeline therapies for C-MET Non-Small Cell Lung Cancer treatment.
* The leading C-MET Non-Small Cell Lung Cancer Companies such as Novartis, Apollomics Inc., Abbvie, Janssen Research and Development , and others.
* Promising C-MET Non-Small Cell Lung Cancer Therapies such as Glumetinib, Telisotuzumab vedotin, Tepotinib, APL-101 Oral Capsules, MCLA-129, Osimertinib, PLB1001 , and others.
Stay informed about the cutting-edge advancements in C-MET Non-Small Cell Lung Cancer Treatments. Download for updates and be a part of the revolution in oncology care @ C-MET Non-Small Cell Lung Cancer Clinical Trials Assessment [https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
C-MET Non-Small Cell Lung Cancer Emerging Drugs Profile
* EGF-816 (Nazartinib): Novartis Oncology
Novarti's lead drug candidate, EGF-816 (Nazartinib), is small molecule in combination with INC280 is in development for the treatment of non-small cell lung cancer. Clinical trials data demonstrated that EGF-816 (Nazartinib) for the treatment of C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) has beneficial effects. The drug is a new molecule which is an epidermal growth factor receptor antagonist that blocks the function of protein EGFR.
* APL 101 (Bozitinib): Appolomics Inc.
Apollomics drug APL 101 (Bozitinib) is an orally administered small molecule currently being evaluated for the treatment of C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) and has demonstrated good safety and efficacy profile in phase II trials. APL 101 (Bozitinib) is an anti-neoplastics which inhibits the C-met protein.
Learn more about C-MET Non-Small Cell Lung Cancer Drugs opportunities in our groundbreaking C-MET Non-Small Cell Lung Cancer Research and development projects @ C-MET Non-Small Cell Lung Cancer Unmet Needs [https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.
* Subcutaneous
* Intravenous
* Oral
* Intramuscular
* Molecule Type
C-MET Non-Small Cell Lung Cancer Products have been categorized under various Molecule types such as
* Small molecules
* Natural metabolites
* Monoclonal antibodies
* Product Type
Discover the latest advancements in C-MET Non-Small Cell Lung Cancer Treatment by visiting our website. Stay informed about how we're transforming the future of oncology @ C-MET Non-Small Cell Lung Cancer Market Drivers and Barriers, and Future Perspectives [https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the C-MET Non-Small Cell Lung Cancer Pipeline Report
* Coverage- Global
* C-MET Non-Small Cell Lung Cancer Companies- Novartis, Apollomics Inc., Abbvie, Janssen Research and Development, and others.
* C-MET Non-Small Cell Lung Cancer Therapies- Glumetinib, Telisotuzumab vedotin, Tepotinib, APL-101 Oral Capsules, MCLA-129, Osimertinib, PLB1001, and others.
* C-MET Non-Small Cell Lung Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* C-MET Non-Small Cell Lung Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
For a detailed overview of our latest research findings and future plans, read the full details of C-MET Non-Small Cell Lung Cancer Pipeline on our website @ C-MET Non-Small Cell Lung Cancer Drugs and Companies [https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC): Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) - DelveInsight's Analytical Perspective
* In-depth Commercial Assessment
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Collaboration Deals
* Late Stage Products (Phase III)
* EGF 816 (Nazartinib): Novartis
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* APL 101 (Bozitinib): Apollomics Inc.
* Drug profiles in the detailed report.....
* Pre-clinical and Discovery Stage Products
* Drug profiles in the detailed report.....
* Inactive Products
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Key Companies
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Key Products
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC)- Unmet Needs
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC)- Market Drivers and Barriers
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC)- Future Perspectives and Conclusion
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Analyst Views
* C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cmet-nonsmall-cell-lung-cancer-pipeline-2024-fda-approvals-clinical-trials-therapies-moa-roa-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release C-MET Non-Small Cell Lung Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight here
News-ID: 3560475 • Views: …
More Releases from ABNewswire
UK Taxpayers Seek Easy Tax Software as Digital Filing Becomes the New Normal
As digital tax filing becomes the default across the UK, taxpayers are increasingly searching for easy tax software that removes complexity from self assessment and online submissions. With more people managing freelance income, property earnings, and side work alongside PAYE employment, demand for simpler tools is rising. Industry data from Pie shows sustained growth in users choosing guided, app-based tax platforms over manual forms and spreadsheets.
LONDON, United Kingdom - February…
Top CPA in Dallas, Texas, Advises Clients to Prepare for Potential Shifts in Tax …
Dallas, TX - With comprehensive tax reform proposals under consideration, taxpayers and business owners face a landscape of potential changes that could reshape financial strategies for years to come. The proposals encompass wide-ranging modifications to individual deductions, capital gains treatment, estate tax exemptions, and business tax structures that require proactive planning and careful evaluation.
Jeff Badu, a well-known tax accountant in Dallas, Texas [https://www.abnewswire.com/pressreleases/tax-professional-in-dallas-tx-highlights-importance-of-early-retirement-planning-as-many-approach-retirement-unprepared_785667.html], advises clients to review their current tax…
Top Plant Maintenance Contractor in Bay Area CA Notes Wave of Office Relocations …
Bay Area, CA - As commercial lease expirations accelerate through 2026, businesses across Silicon Valley are rethinking their office strategies. Companies are downsizing while simultaneously upgrading to class A office spaces featuring biophilic design elements that integrate nature into the workplace. This shift reflects a strategic response to the hybrid work era, where premium environments can make the difference in bringing employees back to the office.
Jennifer Farmer, a plant maintenance…
Ardmore, PA Holistic Doctor Brings Enhanced Candida Cleansing Therapy in the Mai …
Ardmore, PA - Live Well Holistic Health Center announces enhanced treatment protocols following Dr. Martin Orimenko's completion of advanced training with renowned mentors Michael Lebowitz and Noah Lebowitz of Supreme Nutrition. The specialized training has equipped the practice with powerful new techniques for uncovering hidden causes of patient symptoms, particularly benefiting those seeking candida cleansing therapy in the Main Line, PA [https://www.abnewswire.com/pressreleases/natural-medicine-practitioner-in-ardmore-pa-marks-15-years-helping-main-line-patients-address-the-root-cause-of-illness_785743.html].
Dr. Martin Orimenko, a trusted natural medicine practitioner in…
More Releases for Small
Succeeding Small Launches Small Business Give-Back Giveaway in Celebration of Sm …
Succeeding Small Launches Small Business Give-Back Giveaway in Celebration of Small Business Month
Honoring Local Colorado Springs Businesses That Make a Difference in Their Community
COLORADO SPRINGS, CO - Succeeding Small, a go-to guide for small business success in small business marketing, is celebrating Small Business Month with the launch of its Small Business Give-Back Giveaway - a contest aimed at honoring the small, service-based businesses that make a meaningful difference in…
Small Molecules, Big Impact: The Rise of the Small Molecule Immunomodulators Mar …
Small Molecule Immunomodulators Market worth $270.8 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Small Molecule Immunomodulators Market - (By Product (Disposable, Reusable), By Application (Colorectal, Thoracic, Orthopedic, Ophthalmology, Neurosurgery, Cardiac Surgery, Gynecology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to…
Powering Small: Small Gas Engines Market Advances (2023-2032)
"According to the research report, the global small gas engines market was valued at USD 2.75 billion in 2022 and is expected to reach USD 4.23 billion by 2032, to grow at a CAGR of 4.4% during the forecast period."
Polaris Market Research has recently published the latest update on Small Gas Engines Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis,…
Small Batch Freeze Dryer Market: Increasing Demand for Small-scale Freeze Drying …
Global Small Batch Freeze Dryer Market Overview:
The Small Batch Freeze Dryer market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Small Batch Freeze Dryer market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and…
Global Small Gas Engines Market, Global Small Gas Engines Industry, Covid-19 Imp …
The Small Gas Engines market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Small Gas Engines Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Small Gas Engines market. The report focuses on well-known providers…
Small Appliances Market: Strategic Assessment of Emerging Technologies in Small …
Small appliances market is forecasted to grow substantially in all market segments through 2016 owing to the rise in living standards and need for more comfort. Small appliance industry consists of home appliances that are movable or partially movable and can be used on tables, counters, or other platforms. The growth of small appliances market is expected to be driven by product innovation, upgradation of existing products, and value-added features…
